Magnetic resonance (MR) imaging is increasingly being used in patients with gynaecological disorders due to its high contrast resolution compared to computed tomography (CT) and ultrasound. In women presenting with an adnexal mass, ultrasound remains the primary imaging modality in the detection and characterisation of such lesions. However, in recent years overwhelming evidence has accumulated for the use of MR imaging in patients with indeterminate adnexal masses particularly in younger women and where disease markers are unhelpful. In staging ovarian cancer and for evaluating therapeutic response MR imaging is as accurate as CT but CT remains the imaging modality of choice because it is more widely available and quicker. This article reviews that evidence and outlines a place for the use of MR imaging in ovarian cancer.

Author

S.A.A. Sohaib and R.H. Reznek

Contact Details

Corresponding address:
Dr S.A. Sohaib, Department of Radiology, Royal Marsden Hospital, Fulham Road,
London, SW3 6JJ, UK

Reference

ICIS Cancer Imaging Volume 7 Special Issue A
DOI: 10.1102/1470-7330.2007.9046

Date Posted

1 October 2007

Print PDF

Size

819.90 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	3 seconds
ADSL 512Kb/s (Broadband):	12 seconds
64 Kb/s (ISDN):	1 minute 42 seconds
33.3 Kb/s (Typical Modem):	3 minutes 16 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.